- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0000436

About Styrax Pharma Private Limited
Data last updated:
Styrax Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 July 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24230AP1995PTC098146. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹13.12 Cr. It was formerly known as Vaya Jayanthi Drugs Private Limited. It is led by directors including Suryadevara Venkateswara Rao (Managing Director) and Sreenath Suryadevara.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 27B J. N. Pharmacity Parawada Vishakapatnam, Visakhapatnam, Andhra Pradesh, India – 531021.
As per the financials filed for FY 2024, the company reported a revenue of ₹260.24 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹9.16 Cr (net margin 3.5%) and EBITDA of ₹29.31 Cr (EBITDA margin 11.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.
The company has about 264 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Styrax. As per MCA filings, the company has open charges of ₹187.82 Cr and satisfied charges of ₹163.68 Cr on record. Court records list 11 cases involving the company, including 2 filed by the company and 9 filed against it; 8 cases are pending. The company has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021. Its 5 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Sodium Metal Pvt Ltd with revenue of ₹273.32 Cr.
Styrax Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0000436). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website styraxpharma.com.
Company details
CIN history
Styrax Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230AP1995PTC098146, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230AP1995PTC098146 | Current |
| U24230TG1995PTC020995 | Previous |
| U24230AP1995PTC020995 | Previous |
Recognitions & Rankings of Styrax Pharma
Contact details
Styrax Pharma Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is styraxpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 27B J. N. Pharmacity Parawada Vishakapatnam, Visakhapatnam, Andhra Pradesh, India – 531021
- IndustryPharma, API Manufacturers
To see the full contact details of Styrax Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Styrax Pharma operates one associated brand: Styrax. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer & supplier of active pharmaceutical ingredients and intermediates | styraxpharma.com |
Business activity
The main business activity of Styrax Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Styrax Pharma Private Limited, buy the company report.
Financials of Styrax Pharma Private Limited
FY 2025 filings availableStyrax Pharma Private Limited reported revenue of ₹260.24 Cr (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.16 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.3% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Styrax Pharma Private Limited, buy the company report.
Board of directors of Styrax Pharma Private Limited
Styrax Pharma has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenath Suryadevara Also directs: Auctus Life Sciences LLP, Styrax Laboratories Private Limited | Director | 18 Apr 2019 | 7 Years 7 Months | Current |
| Lakshmi Devi Suryadevara | Director | 18 Apr 2019 | 7 Years 7 Months | Current |
| Suryadevara Venkateswara Rao | Managing Director | 23 Jun 2014 | 12 Years 4 Months | Current |
Peer comparison
Styrax Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sodium Metal Pvt Ltd | ₹273.32 Cr (FY 2023) | -11.0% | Vadodara, Gujarat, India | |||
| Saraf Chemicals Private Limited | ₹271.96 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Styrax Pharma Private Limitedthis company | ₹260.24 Cr (FY 2024) | ₹9.16 Cr | 3.5% | 4.0% | 264 | Visakhapatnam, Andhra Pradesh, India |
| Rakshit Drugs Private Limited | ₹256.13 Cr (FY 2024) | -3.0% | Hyderabad, Telangana, India | |||
| East India Pharmaceutical Works Limited | ₹249.94 Cr (FY 2024) | Kolkata, West Bengal, India | ||||
| Rakshit Pharmaceuticals Limited | ₹238.14 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Styrax Pharma Private Limited, buy the company report.
Auditor
Styrax Pharma Private Limited is audited by V.M.G.K. MURTY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.M.G.K. MURTY & CO | FY 2023 | 002223S |
Shareholding
The shareholding of Styrax Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Styrax Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Oct 2023 | 100803552 | Others | ₹45 Cr | Open | |
| 29 Mar 2023 | 100704273 | Yes Bank Limited | ₹1.5 Cr | Open | |
| 29 Mar 2023 | 100706996 | Yes Bank Limited | ₹20 Cr | Open | |
| 23 Mar 2023 | 100706999 | Axis Bank Limited | ₹20.8 Cr | Open | |
| 01 Mar 2023 | 100682072 | Others | ₹35 Cr | Open |
To see the full charge records of Styrax Pharma Private Limited, buy the company report.
Total charge records: 26 View all charges
Deals & funding
Styrax Pharma Private Limited has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Aurore Life Sciences Private Limited |
| Jul 2017 | Rights issue | ₹17.71 Cr | Investors: Aurore Life Sciences Private Limited |
| Nov 2015 | Funding round | ₹14 Cr | Investors: 4 individuals |
| Oct 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
To see the full deal history of Styrax Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Styrax Pharma Private Limited has 11 court cases on record: 2 filed by Styrax Pharma, 9 filed against it. 8 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 8 | 7 |
| High courts | 2 | 0 | 0 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1901-Energy Laws - Electricity, Petroleum, Oil and Natural Gas : Energy laws - Electricity, Petroleum, Oil and Natural Gas) | Filed against the company by The State of Andhra Pradesh | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by M/S R R Enterprises Rep by G V S S R Krishna | Disposed |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by M/S.Greenfy India Rep. by Its Managing Partner, B.Naga Subhashini | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by Greenfy India Rep.By Its Managing Partner, B.Naga Subhashini | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed against the company by Greenfy India Rep.By Its Managing Partner Smt.B.Naga Subhashini | Pending |
To see the full case history of Styrax Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Styrax Pharma Private Limited was last rated by Care on 02 Nov 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 02 Nov 2021 |
To see the full credit ratings and regulatory alerts of Styrax Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Styrax Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Styrax Pharma Private Limited has a workforce of 264 employees on its EPFO records as of Feb 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 264 |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Styrax Pharma Private Limited, buy the company report.
GST
Styrax Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Styrax Pharma Private Limited, buy the company report.
Recent activity
Styrax Pharma Private Limited has 11 board changes on record since 2008: 3 appointments and 8 cessations. The latest: Sreenath Suryadevara ceased to be Additional Director on 30 Sep 2019.
60 earlier events are in the company report.
Frequently asked questions
Styrax Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 July 1995 (31+ years old) and is registered under CIN U24230AP1995PTC098146.
Styrax Pharma has 3 current directors:
- Suryadevara Venkateswara Rao - Managing Director
- Sreenath Suryadevara - Director
- Lakshmi Devi Suryadevara - Director
The latest financial statements of Styrax Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
No. Styrax Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Styrax Pharma is U24230AP1995PTC098146. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Styrax Pharma has 11 court cases on record: 2 filed by the company and 9 filed against it. 8 are pending. Most are in the district courts.
Styrax Pharma was incorporated on 10 July 1995, making it 31+ years old. It is registered with the Registrar of Companies, Vijayawada.
Styrax Pharma has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021.
The peers of Styrax Pharma by revenue are Sodium Metal Pvt Ltd, Saraf Chemicals Private Limited, Rakshit Drugs Private Limited, East India Pharmaceutical Works Limited, Rakshit Pharmaceuticals Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sreenath Suryadevara ceased to be Additional Director on 30 Sep 2019. Lakshmi Devi Suryadevara was appointed as Director on 18 Apr 2019. Rajender Juvvadi Rao ceased to be Director on 18 Apr 2019. Styrax Pharma has 11 board changes on record in total.
Yes, Styrax Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0000436).

